Efficacy and safety of carbon ion radiotherapy for primary skull base tumor

Efficacy and safety of carbon ion radiotherapy for primary skull base tumor - carbon ion radiotherapy for skull base tumor

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007903

Enrollment

Registered

2012-05-07

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary skull base tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Histologically or radiologicaly proven primary skull base tumor 2. Without lymph node and/or distant metastasis 3. Measureable tumor 4. Age between 16 and 80 years old 5. PS 0-3 6. Life expectancy more than 6 months 7. Informed consent

Exclusion criteria

Exclusion criteria: 1. Obvious tumor invasion to central nervous system 2. Past history of chemotherapy within 4 weeks before treatment 3. Uncontrolled infectious disease 4. Past history of irradiation to the target 5. Uncontrolled severe complication 6. Active double cancers 7. In pregnancy or during the lactation period 8. Other medical or psychological unsuitable reasons

Design outcomes

Primary

Measure	Time frame
Local control rate at 3 years	—

Countries

Japan

Contacts

Public ContactShin-ei Noda

Gunma University Gunma University Heavy Ion Medical Center

gunmaciru-office@umin.ac.jp027-220-8378

Outcome results